Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y.
Rascol O, et al. Among authors: grouin jm.
Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922.
Mov Disord. 2010.
PMID: 20063435
Clinical Trial.